for a plan year before 2028—
(aa)#
for a generic drug or a preferred drug that is a multiple source drug (as defined in section 1396r–8(k)(7)(A)(i) of this title ), $1 or, if less, the copayment amount applicable to an individual under clause (iii); and
(bb)#
for any other drug, $3 or, if less, the copayment amount applicable to an individual under clause (iii); and